Who Exports Asava from India — 86 Suppliers Behind a $458.0K Market
India's asava export market is supplied by 86 active exporters who collectively shipped $458.0K across 1,399 shipments. SAVA HEALTHCARE LIMITED leads with a 44.8% market share, followed by DABUR INDIA LIMITED and UNICORN EXPORTS. The top 5 suppliers together control 78.0% of total export value, reflecting a concentrated market structure.
Top Asava Exporters from India — Ranked by Export Value
SAVA HEALTHCARE LIMITED is the leading asava exporter from India, holding a 44.8% share of the $458.0K market across 1,399 shipments from 86 exporters. The top 5 suppliers — SAVA HEALTHCARE LIMITED, DABUR INDIA LIMITED, UNICORN EXPORTS, GREENSHIP EXPORTS, KERALA AYURVEDA LIMITED — collectively control 78.0% of total export value, indicating a highly concentrated market. Individual shares are: SAVA HEALTHCARE LIMITED (44.8%), DABUR INDIA LIMITED (13.4%), UNICORN EXPORTS (9.0%), GREENSHIP EXPORTS (7.5%), KERALA AYURVEDA LIMITED (3.4%).
Top Asava Exporters from India
Ranked by export value · 86 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SAVA HEALTHCARE LIMITED CENTASAVA HUMAN PLACENTA EXTRACT GELPHARMACEUTICAL PRODUCT CENTASAVA HUMAN PCENTASAVA HUMAN PLACENTA EXTRACT GEL PACK SIZE 1 X 20 GM | $205.0K | 1 | 44.8% |
| 2 | DABUR INDIA LIMITED KUMARYASAVA 450MLVASAVALEHA 250GMKUMARYASAVA 450 ML | $61.3K | 2 | 13.4% |
| 3 | UNICORN EXPORTS AYUR-RISHTAM ,KASAVAM ,TAILAM ,BALASWAGAAYURVEDIC : PUNAMNAVASAVAM - 80 NOS, BHRAYURVEDIC PRODUCT KANAKASAVAM | $41.2K | 1 | 9.0% |
| 4 | GREENSHIP EXPORTS LOHASAVAMPIPPALYASAVAM 450MLKUMARYASAVAM 450 ML | $34.4K | 4 | 7.5% |
| 5 | KERALA AYURVEDA LIMITED AYURVEDIC PRODUCTS-PUNARNAVASAVAM 450 MLLOHASAVAM -450MLSARIBADYASAVAM -450ML | $15.5K | 2 | 3.4% |
| 6 | THE ARYA VAIDYA PHARMACY COIMBATORE LIMITED AYUR-RISHTAM ,KASAVAM ,TAILAM ,BALASWAGANIMBAMRUTHASAVAM 450MLARDRAKASAVAM 450ML | $12.6K | 3 | 2.8% |
| 7 | THE ARYA VAIDYA PHARMACY (COIMBATORE) LIMITED AYUR-RISHTAM ,KASAVAM ,TAILAM ,BALASWAGANIMBAMRUTHASAVAM 450MLARDRAKASAVAM 450ML | $8.6K | 4 | 1.9% |
| 8 | SREE EXPORTS PIPPALYASAVAM 450MLLOHASAVAM 450MLKANAKASAVAM 450ML | $6.5K | 1 | 1.4% |
| 9 | ASHTANGA VAIDYAM AYURVEDICS LOHASAVAMPIPPALYASAVAM 450MLKUMARYASAVAM 450 ML | $5.8K | 5 | 1.3% |
| 10 | SANIYA EXPORTS & IMPORTS PIPPALYASAVAM 450MLLOHASAVAM 450MLKANAKASAVAM 450ML | $4.5K | 1 | 1.0% |
| 11 | NAGARJUNA HERBAL CONCENTRATES LTD KUMARYASAVAM 450MLSHARIBADYASAVAM 450MLPUNARNNAVAASAVAM 450ML | $3.7K | 4 | 0.8% |
| 12 | SALTS GLOBAL LOGISTICS PRIVATE LIMITED | $3.4K | 1 | 0.8% |
| 13 | 3PHALA AYURCENTRE PRIVATE LIMITED LOHASAVAM -450MLSARIBADYASAVAM -450MLKUMARYASAVAM -450ML | $2.9K | 1 | 0.6% |
| 14 | NAGARJUNA HERBAL CONCENTRATES LIMITED KUMARYASAVAM 450MLSHARIBADYASAVAM 450MLPUNARNNAVAASAVAM 450ML | $2.9K | 5 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Asava exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| SAVA HEALTHCARE LIMITED | Not Listed | Yes, as of 2026 | Not Listed | Not verified | WHO-GMP certified facility as of 2026. |
| DABUR INDIA LIMITED | Not Listed | Not Listed | Not Listed | Not verified | No specific regulatory certifications found. |
| KERALA AYURVEDA LIMITED | Not Listed | Not Listed | Not Listed | Not verified | No specific regulatory certifications found. |
| THE ARYA VAIDYA PHARMACY (COIMBATORE) LIMITED | Not Listed | Not Listed | Not Listed | Not verified | No specific regulatory certifications found. |
| NAGARJUNA HERBAL CONCENTRATES LTD | Not Listed | Not Listed | Not Listed | Not verified | No specific regulatory certifications found. |
TransData Nexus reviewed the regulatory standing of 5 leading Asava exporters from India. 0 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 0 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Asava sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as India's "Bulk Drug Capital," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The city is renowned for its production of active pharmaceutical ingredients (APIs) and has a strong focus on research and development, supported by institutions such as the National Institute of Pharmaceutical Education and Research (NIPER). The Telangana government's initiative to develop "Pharma City" aims to create the world's largest integrated pharmaceutical cluster, further enhancing Hyderabad's capabilities in bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations, contributing nearly 28% of India's pharmaceutical production. This region is home to leading companies such as Zydus Cadila, Intas Pharmaceuticals, and Cadila Pharmaceuticals. The well-established infrastructure, including ports and roads, facilitates efficient manufacturing and distribution. Vadodara, in particular, has emerged as a major center for pharmaceutical industries within Gujarat.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for India's pharmaceutical industry. Mumbai, being the financial capital, hosts the headquarters of major pharmaceutical companies like Cipla and Sun Pharma. The region's proximity to major ports and well-developed logistics infrastructure make it an ideal location for companies focusing on export-oriented production. Additionally, the presence of numerous R&D centers supports innovation in pharmaceutical formulations.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a prominent pharmaceutical manufacturing hub, housing over 1,000 pharmaceutical companies. The region's growth was significantly driven by tax incentives and government support, attracting major players like Dr. Reddy’s Laboratories and Cipla. Baddi is recognized as Asia's largest pharmaceutical hub, contributing substantially to India's pharmaceutical output.
5Sourcing Recommendations
- Leverage Established Suppliers: Given that SAVA Healthcare Limited accounts for 44.8% of "Asava" exports, establishing or strengthening partnerships with this company could ensure a stable supply chain.
- Explore Gujarat's Formulation Capabilities: The Ahmedabad-Vadodara region's expertise in pharmaceutical formulations makes it a viable option for sourcing "Asava." Collaborating with companies in this area could provide access to high-quality products.
- Utilize Mumbai's Export Infrastructure: For international distribution, leveraging the Mumbai-Thane-Raigad region's export infrastructure can facilitate efficient logistics and compliance with global standards.
- Monitor Regulatory Compliance: Ensure that all sourcing partners comply with regulations set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain product quality and legal compliance.
By strategically engaging with these pharmaceutical clusters and key suppliers, TransData Nexus can optimize the sourcing and distribution of "Asava" to meet global demand effectively.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Asava exporters from India
Dabur India Limited — Dabur India to merge with Sesa Care Private Limited
On October 30, 2024, Dabur India Limited announced an agreement to merge with Sesa Care Private Limited, subject to regulatory approvals. Dabur will acquire 51% of Sesa's Cumulative Redeemable Preference Shares from True North for ₹12.59 crore at face value. The enterprise value is estimated between ₹315-325 crore, including ₹289 crore in debt backed by Dabur's corporate guarantee. - IMPACT: This merger is expected to enhance Dabur's Ayurvedic hair care portfolio, potentially increasing Asava exports.
Impact: This merger is expected to enhance Dabur's Ayurvedic hair care portfolio, potentially increasing Asava exports.
SAVA Healthcare Limited — SAVA Herbals launches 30 new SKUs, expanding into B2C market
In August 2024, SAVA Healthcare's herbal division, SAVA Herbals, unveiled 30 new SKUs, marking a significant expansion from its previous B2B focus. The product range now includes gastroenterology, women's and men's health, dermatology, orthopedics, respiratory, and general well-being. - IMPACT: This expansion may boost SAVA Healthcare's market presence and Asava export volumes.
Impact: This expansion may boost SAVA Healthcare's market presence and Asava export volumes.
Dabur India Limited — Dabur announces ₹135 crore investment in new South India facility
In July 2024, Dabur India Limited announced an investment of ₹135 crore to establish a new manufacturing facility in South India. This unit will produce a range of Ayurvedic healthcare, personal care, and home care products, including Dabur Honey, Dabur Red Paste, and Odonil air fresheners. - IMPACT: The new facility is likely to increase production capacity, potentially enhancing Asava export capabilities.
Impact: The new facility is likely to increase production capacity, potentially enhancing Asava export capabilities.
Common Questions — Asava Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which asava supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SAVA HEALTHCARE LIMITED leads with 9 recorded shipments worth $205.0K. DABUR INDIA LIMITED (128 shipments) and UNICORN EXPORTS (5 shipments) are also established high-volume exporters.
Q How many asava manufacturers are there in India?
India has 86 active asava exporters with a combined export market of $458.0K across 1,399 shipments to 37 countries. The top 5 suppliers hold 78.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for asava from India?
Average FOB unit price: $3.41 per unit, ranging from $0.02 to $440.11. Average shipment value: $327.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 86 verified Indian exporters of Asava ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 1,399 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 37 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,399 Verified Shipments
86 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists